Literature DB >> 18032233

What heroin users tell us about overdose.

Catherine T Baca1, Kenneth J Grant.   

Abstract

This study describes overdose experiences of heroin users, both the overdoses they themselves experienced, as well as those that they witnessed. A structured interview was performed with 101 current heroin users in Albuquerque, New Mexico from January 7, 2002 to February 26, 2002. Heroin-related overdoses were found to be common in this sample of heroin users. Three or more persons were reported to be present during 80 of the 95 most recently witnessed overdoses. An ambulance was called in only 42 of the 95 witnessed overdoses. Seventy-five percent of the respondents who witnessed an overdose stated concern over police involvement was an important reason for delay or absence of a 911 call for help. One hundred of the 101 respondents reported willingness, if trained, to use rescue breathing and to inject naloxone to aid an overdose victim. New methods need to be found to reduce heroin overdose death. Scientific studies are needed on the efficacy of take-home naloxone.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18032233     DOI: 10.1300/J069v26n04_08

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  21 in total

1.  Characteristics of drug users who witness many overdoses: implications for overdose prevention.

Authors:  Amy S B Bohnert; Melissa Tracy; Sandro Galea
Journal:  Drug Alcohol Depend       Date:  2011-08-12       Impact factor: 4.492

2.  Policing and risk of overdose mortality in urban neighborhoods.

Authors:  Amy S B Bohnert; Arijit Nandi; Melissa Tracy; Magdalena Cerdá; Kenneth J Tardiff; David Vlahov; Sandro Galea
Journal:  Drug Alcohol Depend       Date:  2010-08-19       Impact factor: 4.492

3.  Preventing opiate overdose deaths: examining objections to take-home naloxone.

Authors:  Alexander R Bazazi; Nickolas D Zaller; Jeannia J Fu; Josiah D Rich
Journal:  J Health Care Poor Underserved       Date:  2010-11

4.  Why are some people who have received overdose education and naloxone reticent to call Emergency Medical Services in the event of overdose?

Authors:  Stephen Koester; Shane R Mueller; Lisa Raville; Sig Langegger; Ingrid A Binswanger
Journal:  Int J Drug Policy       Date:  2017-07-19

5.  Patterns of polysubstance use and overdose among people who inject drugs in Baltimore, Maryland: A latent class analysis.

Authors:  Kristin E Schneider; Ju Nyeong Park; Sean T Allen; Brian W Weir; Susan G Sherman
Journal:  Drug Alcohol Depend       Date:  2019-06-06       Impact factor: 4.492

6.  Police officers' and paramedics' experiences with overdose and their knowledge and opinions of Washington State's drug overdose-naloxone-Good Samaritan law.

Authors:  Caleb J Banta-Green; Leo Beletsky; Jennifer A Schoeppe; Phillip O Coffin; Patricia C Kuszler
Journal:  J Urban Health       Date:  2013-12       Impact factor: 3.671

7.  Attitudes of Australian heroin users to peer distribution of naloxone for heroin overdose: perspectives on intranasal administration.

Authors:  Debra Kerr; Paul Dietze; Anne-Maree Kelly; Damien Jolley
Journal:  J Urban Health       Date:  2008-03-18       Impact factor: 3.671

8.  Knowledge of Good Samaritan Laws and Beliefs About Arrests Among Persons Who Inject Drugs a Year After Policy Change in Baltimore, Maryland.

Authors:  Kristin E Schneider; Ju Nyeong Park; Sean T Allen; Brian W Weir; Susan G Sherman
Journal:  Public Health Rep       Date:  2020-04-07       Impact factor: 2.792

9.  Neighborhood-Level and Spatial Characteristics Associated with Lay Naloxone Reversal Events and Opioid Overdose Deaths.

Authors:  Christopher Rowe; Glenn-Milo Santos; Eric Vittinghoff; Eliza Wheeler; Peter Davidson; Philip O Coffin
Journal:  J Urban Health       Date:  2016-02       Impact factor: 3.671

10.  EMS runs for suspected opioid overdose: implications for surveillance and prevention.

Authors:  Amy Knowlton; Brian W Weir; Frank Hazzard; Yngvild Olsen; Junette McWilliams; Julie Fields; Wade Gaasch
Journal:  Prehosp Emerg Care       Date:  2013 Jul-Sep       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.